Novartis

Novartis, slammed by Korean scandal, tweaks its ethics, compliance policies
Fierce Pharma
Mon, 05/15/17 - 10:37 pm
Novartis
ethics
Korean
compliance
Novartis set to ride Entresto wave, says report
BioPharma Dive
Mon, 05/15/17 - 01:44 pm
Novartis
Entresto
GlaxoSmithKline aims for the whole consumer-health shebang with $10.3B Novartis JV buyout
Fierce Pharma
Mon, 05/15/17 - 09:20 am
consumer health
M&A
GSK
Novartis
Novartis pushes further into pain with Durect deal
BioPharma Dive
Tue, 05/9/17 - 10:45 pm
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
Novartis continues its blitz on NASH deals, grabbing an exclusive tie-up in race to develop cocktails
Endpoints
Thu, 05/4/17 - 08:02 pm
Novartis
NASH
Conatus Pharmaceuticals
Allergan
Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it
Endpoints
Wed, 05/3/17 - 10:52 am
Magenta Therapeutics
Novartis
stem cells
HSC835
Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies
Endpoints
Wed, 05/3/17 - 10:05 am
Novartis
CAR-T
cell therapy
Celyad
How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
Mon, 05/1/17 - 10:59 am
FTC
GSK
Novartis
BRAF inhibitor
MEK inhibitor
melanoma
Array Biopharma
M&A
5 Big Drugmakers With Important Catalysts in May
Motley Fool
Sun, 04/30/17 - 01:00 pm
FDA
Merck
Keytruda
Isentress
Novartis
PKC412
Novo Nordisk
nonacog beta pegol
Sanofi
Regeneron
Kevzara
Novartis bags FDA OK for Rydapt, adding a new chemo combo drug for AML
Endpoints
Sat, 04/29/17 - 10:02 am
Novartis
FDA
Rydapt
chemotherapy
AML
acute myeloid leukemia
Novartis slapped with $49m fine over kickbacks
Drug Delivery Business News
Fri, 04/28/17 - 11:46 am
Novartis
kickbacks
South Korea
Exelon
1Q17 Earnings for Novartis’s Alcon, Its Eye Care Business
Market Realist
Fri, 04/28/17 - 11:42 am
Novartis
earnings
Alcon
eye care
eye health
Novartis looks earlier as biotech gets too expensive
BioPharma Dive
Tue, 04/25/17 - 11:27 pm
Novartis
M&A
earnings
Novartis beats 1Q profit forecasts
Yahoo/AP
Tue, 04/25/17 - 11:31 am
Novartis
earnings
With late-stage data in on the CGRP migraine drug erenumab, Novartis and Amgen rework commercialization pact
Endpoints
Tue, 04/25/17 - 11:03 am
Novartis
Amgen
CGRP blockers
migraines
erenumab
J&J, Takeda among interested in Brazil's Hypermarcas, sources say
Yahoo/Reuters
Mon, 04/24/17 - 10:04 pm
JNJ
Takeda
Hypermarcas
Brazil
M&A
Novartis
Novartis’s 1Q17 Estimates for Alcon
Market Realist
Mon, 04/24/17 - 10:17 am
Novartis
Alcon
earnings
eye health
Novartis’s 1Q17 Estimates: Innovative Medicines Segment
Market Realist
Sun, 04/23/17 - 09:58 am
Novartis
earnings
Analysts Expect Novartis’s Revenues to Remain Flat in 1Q17
Market Realist
Sat, 04/22/17 - 01:21 pm
Novartis
earnings
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease
FOX Business
Sat, 04/22/17 - 01:12 pm
Novartis
Alzheimer's disease

Pages